#151021

Anti-CyclinB1 [V152]

Cat. #151021

Anti-CyclinB1 [V152]

Cat. #: 151021

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Cyclin B1

Class: Monoclonal

Application: FACS ; IHC ; WB

Reactivity: Mammalian

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Gannon

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CyclinB1 [V152]
  • Alternate name: CCNB1; Cyclin B1; G2/Mitotic-Specific Cyclin B1; CCNB
  • Research fields: Cancer;Cell biology;Genetics
  • Clone: V152
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Mammalian
  • Host: Mouse
  • Application: FACS ; IHC ; WB
  • Description: Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). Cyclin B1 is a marker of cell proliferation and a key component of the cell cycle progression machinery. Cyclin B1 may prove to be a prognostic marker in neoplasia.
  • Immunogen: His tagged Hamster Cyclin B1 expressed in bacteria, harvested from inclusion bodies, extracted with 6M guanidine HC1 and purified on Nickel beads.
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Cyclin B1
  • Target background: Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). Cyclin B1 is a marker of cell proliferation and a key component of the cell cycle progression machinery. Cyclin B1 may prove to be a prognostic marker in neoplasia.

Applications

  • Application: FACS ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: '-15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Gurden et al. 2010. J Cell Sci. 123(Pt 3):321-30. PMID: 20053638.
  • Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F.
  • Geley et al. 2001. J Cell Biol. 153(1):137-48. PMID: 11285280.
  • Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint.
  • Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
  • Minemoto et al. 2001. Exp Cell Res. 262(1):37-48. PMID: 11120603.
  • Brandeis et al. 1998. Proc Natl Acad Sci U S A. 95(8):4344-9. PMID: 9539739.
  • Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.